Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency

Laura Guantay, Cintia Garro, Sebastián Omar Siri, María Florencia Pansa, Sonja Ghidelli‐Disse, Natalia S. Paviolo, Ana C. Racca, Viviana E. Nicotra, Caius G. Radu, José Luís Bocco, Rosana Felice, Keith H. Jansson, Katja Remlinger, Alejandro Amador, Euan A. Stronach, K. Coleman, Marcel Muelbaier, Gerard Drewes, Isro Gloger, Kevin P. Madauss, Manuela E. García, Vanesa Gottifredi, Gastón Soria